Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study.

[1]  G. Pilkington.  Tumour Cell Migration in the Central Nervous System , 1994, Brain pathology.

[2]  X. Yang,et al.  Expression of CD44 in human lung tumors. , 1994, Cancer research.

[3]  Erwin G. Van Meir,et al.  Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. , 1993, Cancer research.

[4]  G. Screaton,et al.  CD44 and cancer screening , 1993, The Lancet.

[5]  P. Herrlich,et al.  Splicing choice from ten variant exons establishes CD44 variability. , 1993, Nucleic acids research.

[6]  P. Herrlich,et al.  Prevention of tumor metastasis formation by anti-variant CD44 , 1993, The Journal of experimental medicine.

[7]  G. Screaton,et al.  CD44 and cancer , 1993, The Lancet.

[8]  A. Bignami,et al.  Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. , 1992, Experimental cell research.

[9]  D. Tarin,et al.  Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.

[10]  Erwin G. Van Meir,et al.  Differential expression of the CD44 molecule in human brain tumours , 1992, International journal of cancer.

[11]  L. Becker,et al.  Localization of the CD44 Glycoprotein to Fibrous Astrocytes in Normal White Matter and to Reactive Astrocytes in Active Lesions in Multiple Sclerosis , 1991, Journal of neuropathology and experimental neurology.

[12]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[13]  M. Amiot,et al.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.

[14]  K. Miyake,et al.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.

[15]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[16]  R. Schulte,et al.  Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. , 1990, Experimental cell research.

[17]  L. Picker,et al.  Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types , 1989, The Journal of cell biology.

[18]  R. Stern,et al.  The extracellular matrix of the central and peripheral nervous systems: structure and function. , 1988, Journal of neurosurgery.

[19]  William,et al.  Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.

[20]  A. Steere,et al.  A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. , 1986, Science.

[21]  E. Butcher,et al.  Homing Receptors and the Control of Lymphocyte Migration , 1986, Immunological reviews.

[22]  C. Isacke,et al.  Structural heterogeneity of human Pgp-1 and its relationship with p85 , 2004, Immunogenetics.